New research highlights the challenges in identifying and validating targets for small molecules aimed at addressing protein misfolding and aggregation in neurodegenerative diseases. This study underscores the complexity of developing effective therapies for these conditions.
targeting protein misfolding and aggregation in neurodegenerative diseases challenges for the identification and validation of targets for small molecules
Original title: “Targeting protein misfolding and aggregation in neurodegenerative diseases: challenges for the identification and validation of targets for small molecules.”